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Abstract 
 
Introduction and aims: It is necessary to ascertain current prescribing of antibiotics for upper respiratory 
tract infections (URTIs) to address potential overuse. A retrospective analysis was conducted of all 
prescriptions for URTIs among ten public primary healthcare centres in Kedah, Malaysia from 1
st
 January 
to 31
st
 March 2014. Results: A total of 123,524 prescriptions were screened and analysed. Of these, 7129 
prescriptions were for URTI, with 31.8% (n=2269) containing antibiotics. Macrolides were the most 
commonly prescribed antibiotic constituting 61% (n=1403) of total antibiotics prescribed. There was a 
statistically significant association between different prescribers and diagnoses (p=0·001) and a weak 
positive trend suggesting family medicine specialists  are more competent in antibiotic prescribing, 
followed by medical officers and assistant medical officers Ĳ ā. Conclusions: Prescribing practices 
of some prescribers were inconsistent with current guidelines encouraging resistance development. 
National antimicrobial stewardship programmes and further educational initiatives are ongoing in 
Malaysia to improve antibiotic use 
 
Key words: Inappropriate use of antibiotics; upper respiratory tract infections; primary healthcare centres; 
guidelines, antibiotics stewardship programmes; Malaysia 
 
Introduction 
 
Upper respiratory tract infection (URTI) is a non-specific term used to describe acute infections involving 
nose, paranasal sinuses, pharynx, larynx, trachea, and bronchi caused by several viruses, predominantly 
rhinovirus [1, 2]. A small proportion of cases (0.5-10%) are sometimes accompanied by bacterial 
complication, usually from Group A Streptococci[1, 3]. Consequently routinely prescribing antibiotics to 
treat URTIs is not justified as they have very limited clinical benefit. However, they are frequently 
prescribed in situations where they are not indicated such as in infections with uncertain bacterial or viral 
aetiology  [4-7]. Hence, URTIs represent a major burden to healthcare systems, especially when 
inappropriate antibiotic treatment leads to clinical failure and/ or increase in antibiotic resistance. Clinical 
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failure happens when the prescribed treatment fails to treat the existing infections and patients do not 
improve or deteriorate [8].  
 
Overall, the majority of antibiotics prescribed in ambulatory care are typically to treat respiratory tract 
infections [9], with acute upper respiratory illnesses accounting for the highest proportion of ambulatory 
antibiotic prescriptions [10]. However, the inappropriate prescribing of antibiotics in ambulatory care is a 
long-standing issue. For example in 1992, ambulatory care physicians in the United States wrote almost 
12 million of prescriptions for URTIs and acute bronchitis [11]. Of these, 51% of adults with colds were 
prescribed an antibiotic, 52% in non-specific upper respiratory infections, and 66% in acute bronchitis 
[11]. Uncontrolled and indiscriminate use of antibiotics in ambulatory care increases the risk of resistance 
development, augmented by their low cost and easy accessibility despite concerns [11-14]. 
 
The World Health Organisation (WHO) warned that the rates of resistance among nosocomial and 
community-acquired infections are high and need to be addressed [15]. In fact, common infections are 
now becoming more difficult to treat with standard antibiotics, forcing a shift to newer generations of 
antibiotics, which are more specific and targeted, but more expensive, and with a higher level of side-
effects [15-18]. There is, however, limited number of antibiotics for second-line and third-line therapy 
particularly in low- and middle- income countries (LMICs), resulting  in a greater potential for resistance to 
first-line antibiotics [19]. In addition, there are concerns with the decline in the number of newly approved 
antibiotics due to barriers including resource concerns [17, 20, 21]. This will make managing infections 
increasingly difficult in future years especially among LMICs. 
 
In several countries including Australia, Chile, Europe and Korea, interventions  involving key stakeholder 
groups, including physicians, pharmacists, infection control team as well as managerial staffs have been 
successfully undertaken [22]. These multifaceted campaigns and interventions have resulted in a 
significant reduction in antibiotic use as well as expenditures across those countries [22-29]. However, 
antibiotic consumption continues to be a concern among Asia Pacific countries, where reported rates of 
antibiotic prescription in ambulatory care centres vary from 11·6% to as high as 82% [30-35]. Malaysia 
was ranked within the top eight consumers of antibiotics per person in 2010 [36]. Expenditure on systemic 
antibiotics was the largest expenditure group in 2008 at 433 million Ringgit (US$121 million) vs. 217 
million Ringgit (US$60.6 million) for medicines to treat diabetes and 191 million Ringgit (US$53.3 million) 
for calcium channel EORFNHUV7KHUHZDVDOVRKLJKXWLOLVDWLRQRIDQWLELRWLFVLQ0DOD\VLD¶VSULYDWH
ambulatory care clinics (third highest category), although lower in public primary healthcare centres [7]. 
Antibiotic expenditure in Ministry of Health (MOH) primary care centres is steadily increasing and 
represented 10% of the total drug primary care spending in Malaysia in 2011 [37]. These concerns 
resulted in multiple initiatives across Malaysia by the government and other bodies. This included the 
publication of national antibiotic guidelines for infections including URTIs and more recently the launch of 
the Protocol on Antimicrobial Stewardship Programme (ASP) in 2014. These include developing 
Antimicrobial  Stewardship Teams (AMS Teams), engaging both hospitals and primary care centres (Box 
1) [37]. Updated national antibiotic guidelines have just been launched (May 2015) in Malaysia, which 
include a mobile phone application to facilitate and promote access among prescribers as well as the 
public [38]. In addition, there are also strict instructions regarding the issuing of prescriptions among 
healthcare professionals within primary healthcare centres in Malaysia. Restrictions on the prescribing of 
certain antibiotics among the healthcare professionals have also been emphasized in the national 
antibiotic guidelines (Box 1). 
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Box 1 ± Current situation and initiatives for improving antibiotic prescribing for URTIs among physicians 
and other professionals including those in primary healthcare centres 
 
A) Prescribing guidance for URTIs in primary healthcare centres in Malaysia 
 
Medicines in the Ministry of Health (MOH) Drug Formulary are listed according to the category of 
prescriber-authorization (Dental Consultant, Dental specialist and Dental Officers are also included in 
these categories but only for medicines used in dental treatment): 
 
Category Prescribers 
A* Consultant/specialists for specific indications only 
A Consultant/specialists 
A/KK Consultant/specialists/family physician specialists 
B Medical officers 
C Paramedical staff 
C+ Paramedical staff doing midwifery 
 
  
 Category of 
Prescribers** 
Macrolides J01FA Erythromycin B 
Penicillins 
 
J01CA 
 
Cloxacillin 
Penicillin V 
Amoxycillin 
Amoxicillin+Clavulanate 
B 
C 
B 
A/KK 
Cephalosporins J01DB/C 
Cefuroxime 
Cephalexin 
A/KK 
B 
Tetracyclines J01AA Doxycycline B 
Sulfonamide J01EE Co-Trimoxazole B 
Others  Others  
** MoH Drug Formulary No.1/2015 
 
Summary: 
x FMS can prescribe all categories (A/KK, B and C) of drugs 
x MOs only can prescribe category B and C , need approval and countersigned from FMS if they 
want to prescribe category A/KK drugs 
x AMOs can only prescribe category C, need approval and countersigned from MO or letter of 
authorization if they want to prescribe category B drugs 
 
B) Current regulations for the prescribing of antibiotics for URTIs 
x FMS ± All available suggested antibiotics for URTIs including: Tetracyclines (J01AA) ±doxyxcline; 
cephalosporins (J01DB/C) ± Cefuroxime and cephalexine; penicillins (J01CA) ± penicillin V, 
amoxicillin and amoxicillin + clavulanate, cloxacillin; Sulfonamides (J01EE) ± co-trimoxazole; 
macrolides (J01FA) ± erythromycin. Quinolones are not on the formulary for URTIs (FMS 
physicians manage referral patients from MOs, i.e. typically more complex cases) 
x MOs: Penicillins ± Penicillin V and amoxicillin; macrolides - erythromycin  
x AMOs± penicillin V. AMOs can also issue repeat prescriptions but these must be counter-signed/ 
letter of authorisation by a physician including the MO in the primary health centre. Each AMO 
has a Diploma of Medical Assistant. They are seen as an efficient method to enhance access to 
healthcare professionals given often the limited number of MOs and FMS within public healthcare 
system and the large number of patients seeking medical help. 
 
C) Key goals/ initiatives under the Antimicrobial Stewardship Programme (ASP) 
a) General 
x To improve patient outcomes (e.g. reduce morbidity and mortality from infection)  
x To optimize antimicrobial therapy, by promoting judicious use of antimicrobials, optimizing 
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antimicrobial selection, dosing, route and duration of therapy in order to maximize clinical cure or 
prevent infections.  
x To limit unintended consequences of antibiotic prescribing such as the emergence of 
antimicrobial resistance and adverse drug events. 
x To reduce healthcare cost without adversely impacting quality of care.  
b) For Primary Healthcare Centres 
x Ensure implementation of ASP strategies and activities.  
x Establish formulary restriction and approval systems especially for broadǦspectrum antimicrobials.  
x Ensure implementation of National Antibiotic Guideline, treatment guidelines and clinical 
pathways for common infections (updated in 2015) 
x Ensure necessary action is taken based on surveillance findings.  
x Educate the public, physicians, pharmacists and paramedics about good antimicrobial prescribing 
practice and antimicrobial resistance 
x Evaluate and report surveillance and clinical audit findings and future audit meetings discussing 
future management approaches 
NB: FMS = Family Medicine Specialist; MO = Medical Officer and AMO = Assistant Medical Officer 
 
We have recently published a systematic review regarding the knowledge, perceptions, and behaviour of 
physicians concerning antibiotic prescribing to guide future strategies [22]. We also recently published a 
study describing the prescribing of antibiotics for patients with URTIs among private physicians in 
Malaysia [39]. We found that when assessed against antibiotic knowledge assessment criteria, most 
general practitioners (GPs) had a moderate level of knowledge of prescribing for URTIs. However, 
antibiotic prescriptions could be appreciably reduced as a large number of GPs (85.5%) reported that 
they could reduce antibiotic prescriptions by more than 25% without jeopardizing the outcome of the 
URTIs. As a result, helping to reduce future development of antibiotic resistance  [39].  
 
We are aware there is paucity of data on antibiotic prescribing rates among primary healthcare centres in 
the public healthcare system in Malaysia. These data are important as a baseline for assessing the 
influence of the recently updated national antibiotic guidelines as well as the recent Antimicrobial 
Stewardship Programmes in Malaysia. Consequently, we undertook a prescription analysis to document 
URTI-specific antibiotic prescription rates in public primary healthcare settings in Malaysia prior to these 
recent initiatives. Furthermore, we aimed to investigate the choice, proportion, and adherence to the 
guidelines of oral antibiotics prescribing in patients diagnosed with URTIs among the different healthcare 
professionals in the public sector. Future interventions, if needed, can be planned under the new 
antimicrobial stewardship programme and the national antibiotic guidelines. 
 
Methods 
 
Study design and prescription selection criteria  
 
A retrospective prescription analysis was conducted whereby all prescriptions from 1
st
 January 2014 to 
31
st
 March 2014 were screened and retrieved for further investigation. Prescriptions with diagnosis of 
µ857,¶µWRQVLOOLWLV¶µSKDU\QJLWLV¶µUKLQLWLV¶µFRPPRQFROG¶µVRUHWKURDW¶µFRXJK¶RUµRWLWLVPHGLD¶ZHUH
included in the study. Incomplete prescriptions, missing diagnosis, or prescriptions with more than one 
infection were excluded from the study. This was done to avoid or minimize uncertainty of the diagnosis 
and the purpose of antibiotics in the prescription.  
 
Identification of URTI diagnosis 
All prescriptions were in hard copies, retrieved manually from the pharmacy units from each clinic. The 
selection of prescriptions to be included in the study was based solely on the written diagnosis on the 
prescription, i.e. the written diagnosis and prescribed treatment.  We did not verify the validity and 
accuracy of the diagnosis as we did not have access to specific clinical data for each patient diagnosed 
with a URTI including their symptomatology or laboratory results. .  URTIs were defined, similar to several 
studies in literature, as any encounter with the diagnosis of upper respiratory tract infection including 
pharyngitis, acute tonsillitis, acute sinusitis, rhinitis and otitis media. Other diagnosis and symptomatic 
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encounters such as cough and sore throat were also included as separate diagnosis based on their 
frequent encounters at the healthcare clinics and strong association with respiratory complaints 
[34,39,40-43]. The prescriptions were screened manually by a trained data collector, who is a qualified 
and practicing pharmacist and has a considerable experience and competence in this regard. 
 
Classification and appropriate prescribing of antibiotics 
We reviewed the appropriateness of the antibiotic prescribing based on the recommendations contained 
in the Malaysian National Antibiotic Guidelines. Subsequently, we evaluated SUHVFULEHUV¶FRQIRUPLW\WRWKH
guidelines before the implementation of the more comprehensive surveillance programme in conjunction 
with the launch of the ASP protocol among the healthcare centres in Malaysia [44] . The classification of 
antibiotics used in this study was adapted from WHO Action Programme on Essential Drugs, International 
Network for the Rational Use of Drugs, and the Malaysia National Antibiotic Guideline 2008. The 
antibiotics included in the study were oral antibiotics listed in the formularies of the primary healthcare 
FOLQLFV%R[3DWLHQW¶VDJHGLDJQRVLVFKRLFHRIDQWLbiotics (if prescribed) and the type of prescriber 
were reported on Microsoft Excel spread sheet.     
Study settings and sampling 
 
The study targeted all primary public healthcare centres (n=10) in the district of Kota Setar in the State of 
Kedah, Malaysia. Health care in Malaysia is provided through both the public and private sector. The 
public health care system provides services through a network of tertiary care centres, general hospitals, 
district hospitals, and primary health clinics [45]. All of these centres are centrally administered by the 
Ministry of Health (MoH) and fully subsidised by the government  [45]. In total, there are 897 healthcare 
clinics in Malaysia scattered throughout the country [46]. In every district, there are health district offices 
managing a number of primary health clinics. Kota Setar is the second largest district in Kedah with a 
total population of 366,787 [47], with one major hospital as a referral centre and 10 healthcare clinics , 
serving patients for their primary medical care needs..   
 
Multiple services are provided at these clinics, including general outpatient services, maternal and child 
health services for the urban and sub-urban population of Kota Setar. Other services include family 
health, dental, dietetics and nutrition, health education and promotion, home nursing, radiology, 
pharmacy, adolescent health and community mental services. During this study period, eighty-three 
prescribers were attached to the general Outpatient Department (OPD) and Maternal Child Health Clinic 
(MCH) in all centres. These include 43 medical officers (MOs), 36 assistant medical officers (AMOs) and 
4 family medicine specialists (FMSs) (Box 1). Total patient attendance at all healthcare clinics in Kota 
Setar District during the study period was 135,320 cases. All of the cases presented at the clinics were 
attended by these prescribers. Nurses who see the large portions of patients at the MCH clinics were 
excluded from the study as they were not allowed to prescribe antibiotics.  
The age of the patients in this study were divided into age groups of ten years for consistency as we were 
not looking specifically at children versus adults but the general prescribing of antibiotics for URTIs. 
 
Statistical analysis 
 
The data was entered into Microsoft Excel spread sheet, and then exported to the Statistical Package for 
the Social Sciences (SPSS), version 20 for further analysis. The Kolmogorov-Smirnov test was used for 
testing the normality of the sample distribution. Both descriptive and inferential statistics were used for 
data elaboration. Frequencies and percentages were used to summarize the data. The Jonckheere±
Terpstra test was used to evaluate the trend of association between the tendencies of different group of 
prescribers; i.e. the FMS with the higher qualified education compared to MOs and AMOs with lower 
qualifications towards prescribing antibiotic according to the national antibiotic guideline. Where 
significant associations were reported, effect size was calculated by using Kendall tau correlation 
coefficient. P value of <0.05 was considered to be of statistical significance. 
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Ethical approval 
 
The Medical Research and Ethics Committee Ministry of Health, Malaysia approved the study. The study 
was registered with National Medical Research Register of Malaysia under identity number: NMRR-13-
1231-16769.  
 
Results 
 
Over the three months, 123,524 prescriptions were screened and analysed according to the established 
inclusion and exclusion criteria. 49,251 prescriptions were excluded as they were appointment-based 
prescriptions mainly for chronic conditions. Others were excluded due to criteria as mentioned above. A 
total of 7129 (5.8%) URTI prescriptions met the inclusion criteria, of which 2269 (31.8%) prescriptions 
contained antibiotics. Among the ten centres, four clinics with the highest number of SDWLHQWV¶DWWHQGDQFH
(Clinic 2, 4 ,  6 and 9) contributed to 58.8% of all URTI attendances as shown in Table 1.  
 
Table 1: Prescribing activities at the 10 clinics of District Kota Setar, Malaysia 
 
Clinics Screened 
prescriptions 
Prescriptions with diagnosis of 
URTI (%) 
Clinic 1 8736 783 (11.0) 
Clinic 2 20652 1011 (14.2) 
Clinic 3 10243 591 (8.3) 
Clinic 4 12359 1073 (15.0) 
Clinic 5 9683 411 (5.8) 
Clinic 6  26662 1135 (15.9) 
Clinic 7 6884 353 (4.9) 
Clinic 8 8522 365 (5.1) 
Clinic 9 12962 654 (9.3) 
Clinic 10 6821 753 (10.6) 
Total 123,524 7129 
 
As seen in Table 2, 3445 (48·3%) prescriptions with URTI symptoms were filled for patients (20 years old 
or below) compared with older patients (21 years or above). Little variation was reported between the 
proportion of cases attended by medical officers (n=3946, 55·3%) and assistant medical officers (n=3117, 
43·7%) with equal tendency among both to prescribe antibiotics (34·0% and 29·5% respectively). 
Tonsillitis, otitis media and pharyngitis were listed as major conditions for which antibiotics were 
prescribed (91·3%, 89·8%, and 84·2% respectively).  
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Table 2: Study characteristics by age, prescriber status and diagnosis 
 
Characteristics Number of prescriptions Prescription with 
antibiotics 
N (%) 
3DWLHQWV¶DJH\HDUV 
1-10 
11-20 
21-30 
31-40 
41-50 
51-60 
>60 
 
1968 
1477 
916 
673 
562 
631 
685 
 
644 (32·7) 
498 (33·7) 
314 (34·3) 
219 (32·5) 
185 (32·9) 
165 (26·1) 
165 (24·1) 
Prescriber status 
Family Medicine Specialists 
Medical officers 
Medical assistants 
 
 
66 
3946 
3117 
 
 
7 (10·6) 
1341 (34·0) 
921 (29·5) 
 
Diagnosis 
Nonspecific URTI 
Tonsillitis 
Pharyngitis 
Rhinitis 
Common Cold 
Sore Throat 
Cough 
Otitis Media 
 
6398 
264 
209 
37 
79 
36 
57 
49 
 
1752 (27·4) 
241 (91·3) 
176 (84·2) 
11 (29·7) 
18 (22·8) 
14 (38·9) 
13 (22·8) 
44 (89·8) 
*Missing values=217 
 
 
Table 3 presents the frequency of antibiotics prescribed to patients. Among all antibiotics, macrolides 
(erythromycin ethyl succinate) were the most commonly prescribed antibiotic, constituting of 61% 
(n=1403) of total antibiotics prescribed for all cases, followed by the penicillin group790 (34.8%). The 
range of preferred antibiotics among the different groups of prescribers did not vary. However, more than 
half of patients were prescribed macrolides after consultations with AMOs (55·2%), compared to 44·2% 
and 0·5% following MO and FMS consultations respectively. 
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Table 3: Choice of antibiotics prescribed for URTIs  
 
Antibiotic class ATC Code Name of antibiotic Prescriptions 
for URTIs 
Prescribed by 
FMSs N (%) 
Prescribed by 
MOs N (%) 
Prescribed by 
AMOs N (%) 
Macrolides J01FA Erythromycin 1403 7 (0·5) 621 (44·2) 775 (55·2) 
Penicillins 
 
J01CA 
 
Cloxacillin 
Penicillin V 
Amoxycillin 
Amoxicillin+Clavulanate 
31 
20 
698 
41 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
14 (45·2) 
15 (75·0) 
582 (83·4) 
37 (90·2) 
17 (54·8) 
5 (25·0) 
116 (16·6) 
4 (9·8) 
Cephalosporins J01DB/C 
Cefuroxime 
Cephalexin 
53 
11 
0 (0) 
0 (0) 
51 (96·2) 
10 (90·9) 
2 (3·8) 
1 (9·1) 
Tetracyclines J01AA Doxycycline 2 0 (0) 2 (100) 0 (0) 
Sulfonamide J01EE Co-Trimoxazole 2 0 (0) 2 (100) 0 (0) 
Others  Others 8 0 (0) 7 (87·5) 1 (12·5) 
ATC: Anatomical Therapeutic Chemical
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Among all URTI cases, erythromycin was the most favoured antibiotic in more than 50% of cases, 
except for otitis media. Amoxicillin was preferred as the treatment of choice in otitis media (68.2%). 
The choice of prescribed antibiotics is described in Table 4.  
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Table 4: Antibiotic prescription against specific diagnosis 
 
 
 
 Diagnosis 
Cases 
prescribed 
with 
antibiotics 
Type of antibiotic prescribed 
Erythromycin Cloxacillin Penicillin V Amoxicillin 
Amoxicillin
+ 
Clavulanate Cefuroxime Cephalexin Doxycycline Co-Trimoxazole Others 
  N N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
Nonspecific 
URTI 1752 1110 (63·4) 26 (1·5) 9 (0·5) 526 (30·0) 25 (1·4) 38 (2·2) 11 (0·6) 1 (0·1) 2 (0·1) 4 (0·2) 
Tonsillitis 241 141 (58·5) 2 (0·8) 9 (3·73) 72 (29·8) 9 (3·7) 8 (3·3) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 
Pharyngitis 176 104 (59·1) 0 (0·0) 1 (0·6) 60 (34·1) 4 (2·3) 7 (4·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 
Rhinitis 11 6 (54·5) 0 (0·0) 0 (0·0) 4 (36·4) 0 (0·0) 0 (0·0) 0 (0·0) 1 (9·0) 0 (0·0) 0 (0·0) 
Common Cold 18 14 (77·8) 0 (0·0) 0 (0·0) 4 (22·2) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 
Sore Throat 14 13 (92·9) 1 (7·1) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 
Cough 13 10 (76·9) 0 (0·0) 1 (7·7) 2 (15·4) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 
Otitis Media 44 5 (11·4) 2 (4·5) 0 (0·0) 30 (68.2) 3 (6·8) 0 (0·0) 0 (0·0) 0 (0·0) 0 (0·0) 4(9.1) 
11 
 
The Jonckheere±Terpstra test revealed a statistically significant association between the status of the 
prescriber and the diagnosis (p=0·001). Furthermore, a weak positive trend was reported with FMS 
physicians being more competent in antibiotic prescribing based on their diagnosis, followed by 
PHGLFDORIILFHUV02VDQGDVVLVWDQWPHGLFDORIILFHUV$02VĲ ā1RVLJQLILFDQWDVVRFLDWLRQ
however, was reported among other study variables.  
 
Discussion 
This study highlighted the frequent use of antibiotics for upper respiratory tract infections at public 
primary care settings in Malaysia (Table 2). The prescription rate for URTI was higher than the rate 
observed in another published study on primary care in Malaysia [34]However encouragingly,  the 
antibiotic prescribing rate in URTIs in this study appeared to be lower than reported in other recent 
studies. For example, antibiotics were prescribed in more than 60% for URTI cases in a Malaysian 
district hospital in 2011[40]DQGRIRXWSDWLHQWSUHVFULSWLRQVLQ&KLQD¶VSULPDU\KHDOWKFDUH
facilities in 2009 through 2011 [48]. The differences in rates could be explained by different natures of 
the denominator used in these studies as well as the study setting, data collection period, and the 
difference in the types and availability of antibiotics. It was found in this study, among all screened 
prescriptions, 5.8% were for URTIs, of which 32% contained antibiotics principally for patients over 20 
years old (Table 2).  
 
As documented in the literature and guidelines, only a very limited number of patients with URTIs 
warrant antibiotic treatment [49-53]. However, this study has found antibiotics were frequently 
prescribed for tonsillitis, otitis media and pharyngitis.(Table 2). According to the Center for Disease 
Control and Prevention (CDC), there are several criteria which should be taken into account when 
diagnosing URTIs. This include the presence of tonsillar exudates, tender anterior cervical 
adenopathy, history of fever, and lack of cough [38,54].
 
Patients with none or only one of these 
findings during clinical examination should not be treated with antibiotics [54]. Therefore appropriate 
clinical judgement is fundamental, in addition to ascertaining the bacterial aetiology before antibiotics 
should be prescribed [54]. This practice could be enhanced by local antibiotic guidelines, as well as 
up-to-date information regarding antibiotic use [22]. Prescribers should be well trained and educated 
regarding pertinent guidelines and initiatives to maximize the benefits of antibiotics and reduce 
potential resistance through making the right choices and dosing. This is especially important as 
successful reduction in antibiotic use could result in a rapid drop in resistance rates. This was shown 
in an observational Japanese study where the authors found that 62% of Group A streptococcal 
isolates were resistant to erythromycin when macrolides accounted for 22% of all antibiotic use in 
1974 [55]. By 1988 when the prescribing of macrolides was reduced to only 8% of total antibiotic use, 
less than 2% of group A streptococcal isolates were resistant to erythromycin [55].  
 
Another potential area of concern discovered in this study is the greater prescribing of antibiotics by 
AMOs compared with MOs and FMS physicians in the primary care centres (Table 2). This is despite 
the fact that AMOs should not initiate antibiotics on their own with the exception of penicillin V, but 
must have prescriptions countersigned by MO and FMS. However, this could be explained by the fact 
that the proportion of patients seen by MO and AMOs are almost equal in public primary healthcare 
centres. Moreover, AMOs play integral role in screening and provision of medical care to patients, 
including prescribing for ailments such as URTIs [40]. Because of this, in most clinics AMOs appear to 
prescribe antibiotics which are not in their prescription category without referring the case to the MOs 
or seeking approval from the MOs. This is against current guidelines, clearly explained in the MOH 
Drug Formulary (Box 1).  
 
Overall, we believe from the findings that the extent of antibiotics used and the variation in prescribing 
between the different prescribers in the primary healthcare centres (Table 2) may be attributed to a 
number of factors. We know biomedical factors such as the characteristic of the disease, the clinical 
presentation of the patients, as well as choice of medicines DQGSUHVFULEHUV¶NQRZOHGJH, provided key 
inputs into the decision making [22]. However, other factors ranging from attitudes of the prescribers 
and patients, to managerial constraints and policies can also influence the prescribing decision [22]. 
For instance, FMS physicians only see refractory cases so may not see URTI patients initially ± only 
when the infection persists or when cases are referred to them by the medical officers, which may be 
rare in practice. Variations in choice of antibiotics as well as the use of antibiotics can also be 
potentially explained by other factors. These include firstly, the limited selection of antibiotics that can 
be prescribed by an MO and AMO, if countersigned  and repeated, versus the greater selection of 
antibiotics available to FMS physicians for prescribing (Box 1). Secondly ease of dosing, since 
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erythromycin is administered twice daily compared to the penicillin group, which require three to four 
administrations per day. Thirdly, primary care centres are busy places with long waiting times. In view 
of this, it may be quicker for an MO or AMO to prescribe and/ or recommend an antibiotic rather than 
take considerable time to explain why they are not necessary.  
 
Consequently, health policy makers need to take steps to address these issues. Potential next steps 
should include provision of education among AMOs and MOs with the implementation of new 
antimicrobial stewardship programme and the guidelines. These include emphasizing the use of 
penicillins if needed as first line treatment for URTIs rather than macrolides (Box 2).  In addition, 
greater education should be fostered among patients, that antibiotics are rarely needed for URTIs and 
their inappropriate use will increase antibiotic resistance, building on the current ASP initiatives (Box 
1). In future, potentially  greater swabbing or sensitivity testing could be done as a regular practice as 
testing kits become routine and inexpensive, given the number of patients typically seen each day in 
primary healthcare centres.  
 
Box 2 ± Updates on Antibiotic Guidelines, the Antimicrobial Stewardship Programme 
 
A) Antimicrobial Stewardship Programme updates 
x July 2015 - ASP Roadshow to all regions in the country to provide regular updates on 
antimicrobial prescribing, practice and usage for healthcare professionals as well as 
strengthening the implementation of ASP in all healthcare facilities.  
x In the ASP, prescribing restrictions have again been emphasized as well as emphasizing that 
prescribers should comply with local as well as the national drug formularies including which 
antibiotics for given situations 
 
B) The new National Antibiotic Guideline (NAG) 
1. In formulating the current edition of NAG, numerous considerations were taken into account 
including changes in antimicrobial resistance patterns in various sectors of clinical practice, trends 
in antimicrobial utilization, current guidelines and new clinical data. 
2. For URTIs: 
x For the general sore throat, the modified Centor score as described by McIsaac et al [56] has 
been introduced in the new guideline to help physicians decide which patients need no testing, 
throat culture/rapid antigen detection testing or empiric antibiotic therapy. This is a clinical score 
to reduce unnecessary antibiotic use in patients with sore throats. 
x Penicillin V is still recommended as first line treatment for tonsillitis/pharyngitis with changes in 
dosage frequency from 8 hourly to 12 hourly. It is in Category C, so it can be prescribed by all 
groups of prescribers from AMOs to FMS. 
x Erythromycin has been removed as a preferred treatment in URTIs due to high resistance 
patterns. Other macrolides such as Azithromycin and Clindamycin have been introduced as 
replacements. 
 
We acknowledge that there are a number of limitations in this study. Firstly, we only carried out the 
study among public health centres in Kedah. However we believe for the reasons documented, 
including the fact that the same antibiotic guidelines and ASP are implemented throughout public 
health centres in Malaysia, and that these centres are centrally administered by the MOH with the 
same policies, that this does represent the public sector in Malaysia. In addition, we excluded 
antibiotic prescriptions where more than one indication, where there were incomplete prescriptions or 
missing diagnoses, for the reasons stated earlier.  We also acknowledge that the diagnoses of URTIs 
were based on the written diagnosis on the prescription and we did not verify the accuracy of the 
clinical examination and diagnosis with the prescribers for the reasons documents. However, this is 
similar to a number of database studies where no additional information is included apart from the 
diagnosis and the prescription. Despite these limitations, we believe this is a step forward from our 
first paper with Private GPs in Malaysia where we were just asking them for their treatment intentions 
based on various scenarios. As such, this paper provides a better reflection of the current situation 
regarding antibiotic prescribing in Malaysia. 
 
Finally, we acknowledge we have not undertaken interviews with the various healthcare professionals 
and groups to ascertain the rationale behind their prescribing of antibiotics for URTIs. Nevertheless in 
spite of these caveats, we believe our findings do provide an insight into the current management of 
URTIs among public facilities in Malaysia to help develop and refine future guidance, building on the 
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recent Antimicrobial Stewardship Programme and the updated version of National Antibiotic Guideline 
which have recently been launched in Malaysia (Boxes 1 and 2). This will be the subject of future 
research following dissemination of the new Antimicrobial Stewardship Programmes and guidelines 
(Boxes 1 and 2). The development of scoring systems such as the recently introduced scoring system 
for sore throats in the updated version of National Antibiotic Guidelines  will also be closely monitored 
as part of future research projects.  
 
Conclusion 
 
The prescribing of antibiotics for the management of URTIs in the public sector was found to be 
inconsistent with current guidelines. Proper use of antibiotics is not just the professional role of 
doctors, but can help prevent the emergence of antibiotic resistance. Consequently a better 
understanding of appropriate antibiotic prescribing must be fostered among prescribers to improve 
their use. This includes enhancing physician adherence to standard treatment practices, including 
reserving antibiotic prescribing for URTIs as they are typically viral in origin, as well as prescribing 
penicillins first line where needed.. The introduction of the national antimicrobial stewardship program 
and guidelines in Malaysia should help with planning future initiatives among the primary healthcare 
centres in Malaysia to enhance the appropriate prescribing of antibiotics. This will be the subject of 
future research projects, building on the current findings. 
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Key points 
 
x There have been recent initiatives in Malaysia to improve the prescribing of antibiotics for upper 
respiratory tract infections (URTIs) among prescribers in primary healthcare centres. These 
include guidelines and Antibiotic Stewardship Programmes 
x To assess the need for further initiatives to improve the prescribing of antibiotics for URTIs, it is 
necessary to ascertain current prescribing practices. Consequently, a retrospective analysis was 
conducted of all prescriptions for URTIs among primary healthcare centres from 1
st
 January to 
31
st
 March 2014.  
x During this period, 123,524 prescriptions were screened and analysed of which 7129 
prescriptions were for URTIs, with 31.8% (n=2269) containing antibiotics 
x There was appreciable tendency of medical officers and assistant medical officers to prescribe 
antibiotics for the management of URTIs when a prescription was issued (34.0% and 29.5% 
respectively) versus only 10.6% for Family Medicine Specialists. Tonsillitis, otitis media and 
pharyngitis were the most common indications for antibiotics 
x Macrolides were the most commonly prescribed antibiotic constituting 61% of total antibiotics 
prescribed despite the fact that penicillins are the recommended first line treatment. Erythromycin 
has been removed from national guidelines due to high resistance patterns replaced by 
azithromycin and clindamycin  
x Whilst there appears to be a reduction in the prescribing of antibiotics in primary healthcare 
centres in this study versus previous studies, there are areas of concern with some prescribing 
inconsistent with current guidelines. National antimicrobial stewardship programmes and further 
educational initiatives are ongoing in Malaysia to improve antibiotic use, and their impact needs to 
be monitored in the future. 
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